Biocon nabs Pfizer research and development facility

The 60,000 square foot bench-to-pilot scale biologics research facility at TICEL Bio Park in Chennai, India was acquired by the drugmaker ' s subsidiary Biocon Biologics
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news